Skip to main content
. 2022 Aug 12;14(8):1685. doi: 10.3390/pharmaceutics14081685

Figure 8.

Figure 8

(A) The in vivo biodistribution imaging of HepG2 tumor-bearing mice; (B) The biodistribution imaging of tumor and representative organs; a: ICG; b: CHOL-ICG-LP; c: Dios-ICG-LP. (*: there was significant difference, p < 0.05; **: there was significant difference, p < 0.01).